First Identification of Human Adenovirus 57 (HAdV-57) in Japan
Neutralization tests have been routinely used for the identification of human adenovirus C species (HAdV-C) in Japan until 2007. The aim of this study was to clarify the serological cross-reactivity of antiserum that has been used exclusively in Japan and to describe the first identification of HAdV...
Gespeichert in:
| Veröffentlicht in: | Japanese Journal of Infectious Diseases 2018/07/31, Vol.71(4), pp.259-263 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 263 |
|---|---|
| container_issue | 4 |
| container_start_page | 259 |
| container_title | Japanese Journal of Infectious Diseases |
| container_volume | 71 |
| creator | Tatsumi, Chika Iizuka, Setsuko Mita, Tetsuo Wada, Mieko Hanaoka, Nozomu Fujimoto, Tsuguto |
| description | Neutralization tests have been routinely used for the identification of human adenovirus C species (HAdV-C) in Japan until 2007. The aim of this study was to clarify the serological cross-reactivity of antiserum that has been used exclusively in Japan and to describe the first identification of HAdV type 57 (HAdV-57) in Japan. Anti-HAdV serum to HAdV-1, 2, 5, and 6 was quantitatively evaluated for cross-reactivity to the HAdV-57 isolates. Anti-HAdV-6 serum neutralized HAdV-57 with a concentration that was 32 to 64-fold higher than what was necessary to neutralize homologous HAdV-6. HAdV-1, 2, and 5 strains were not neutralized by anti HAdV-6 serum. Furthermore, 28 HAdV-6 strains isolated from 6,476 clinical samples were re-examined for HAdVs detected in the Shimane Prefecture of Japan from 2005 to 2014. These 28 strains were re-examined by PCR-sequencing techniques using the penton, hexon, and fiber regions. 3 isolates were determined to be HAdV-57. These data show that HAdV-57 had already invaded Japan as early as 2005, and that HAdV-57 strains were misidentified as HAdV-6. |
| doi_str_mv | 10.7883/yoken.JJID.2017.476 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2033384726</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2229067885</sourcerecordid><originalsourceid>FETCH-LOGICAL-c618t-bf3a4409dd1938d45c5593e354d157312d1b46bab13a731da6778ccbdccf07ba3</originalsourceid><addsrcrecordid>eNpdkEtLAzEYRYMovn-BIANudDE172Q2QvHVFsGNug2ZJKOpbaYmM4L_3tTWgm6SfB_nXsIB4ATBgZCSXH617y4MJpPxzQBDJAZU8C2wj6SkJZaEb-c3obTkBNI9cJDSFELMGIK7YA9XAlYVr_bB1Z2PqSvG1oXON97ozrehaJti1M91KIZ533762KeCieJ8NLQvJRMXhQ_FRC90OAI7jZ4ld7y-D8Hz3e3T9ah8eLwfXw8fSsOR7Mq6IZpSWFmLKiItZYaxijjCqEVMEIQtqimvdY2IzqPVXAhpTG2NaaCoNTkE56veRWw_epc6NffJuNlMB9f2SWFICJFUYJ7Rs3_otO1jyL9TGOMK8iyPZYqsKBPblKJr1CL6uY5fCkG11Kt-9KqlXrXUq7LenDpdd_f13NlN5tdnBsYrYJo6_eo2gI6dNzO3LhVI0eXxp3zDmDcdlQvkG6NsjrU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229067885</pqid></control><display><type>article</type><title>First Identification of Human Adenovirus 57 (HAdV-57) in Japan</title><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Tatsumi, Chika ; Iizuka, Setsuko ; Mita, Tetsuo ; Wada, Mieko ; Hanaoka, Nozomu ; Fujimoto, Tsuguto</creator><creatorcontrib>Tatsumi, Chika ; Iizuka, Setsuko ; Mita, Tetsuo ; Wada, Mieko ; Hanaoka, Nozomu ; Fujimoto, Tsuguto</creatorcontrib><description>Neutralization tests have been routinely used for the identification of human adenovirus C species (HAdV-C) in Japan until 2007. The aim of this study was to clarify the serological cross-reactivity of antiserum that has been used exclusively in Japan and to describe the first identification of HAdV type 57 (HAdV-57) in Japan. Anti-HAdV serum to HAdV-1, 2, 5, and 6 was quantitatively evaluated for cross-reactivity to the HAdV-57 isolates. Anti-HAdV-6 serum neutralized HAdV-57 with a concentration that was 32 to 64-fold higher than what was necessary to neutralize homologous HAdV-6. HAdV-1, 2, and 5 strains were not neutralized by anti HAdV-6 serum. Furthermore, 28 HAdV-6 strains isolated from 6,476 clinical samples were re-examined for HAdVs detected in the Shimane Prefecture of Japan from 2005 to 2014. These 28 strains were re-examined by PCR-sequencing techniques using the penton, hexon, and fiber regions. 3 isolates were determined to be HAdV-57. These data show that HAdV-57 had already invaded Japan as early as 2005, and that HAdV-57 strains were misidentified as HAdV-6.</description><identifier>ISSN: 1344-6304</identifier><identifier>EISSN: 1884-2836</identifier><identifier>DOI: 10.7883/yoken.JJID.2017.476</identifier><identifier>PMID: 29709969</identifier><language>eng</language><publisher>Japan: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee</publisher><subject>Adenoviruses ; Cross-reactivity ; fiber ; hexon ; Homology ; human adenovirus 57 ; Neutralization ; neutralization test ; penton</subject><ispartof>Japanese Journal of Infectious Diseases, 2018/07/31, Vol.71(4), pp.259-263</ispartof><rights>Authors</rights><rights>Copyright Japan Science and Technology Agency 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c618t-bf3a4409dd1938d45c5593e354d157312d1b46bab13a731da6778ccbdccf07ba3</citedby><cites>FETCH-LOGICAL-c618t-bf3a4409dd1938d45c5593e354d157312d1b46bab13a731da6778ccbdccf07ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29709969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tatsumi, Chika</creatorcontrib><creatorcontrib>Iizuka, Setsuko</creatorcontrib><creatorcontrib>Mita, Tetsuo</creatorcontrib><creatorcontrib>Wada, Mieko</creatorcontrib><creatorcontrib>Hanaoka, Nozomu</creatorcontrib><creatorcontrib>Fujimoto, Tsuguto</creatorcontrib><title>First Identification of Human Adenovirus 57 (HAdV-57) in Japan</title><title>Japanese Journal of Infectious Diseases</title><addtitle>Jpn J Infect Dis</addtitle><description>Neutralization tests have been routinely used for the identification of human adenovirus C species (HAdV-C) in Japan until 2007. The aim of this study was to clarify the serological cross-reactivity of antiserum that has been used exclusively in Japan and to describe the first identification of HAdV type 57 (HAdV-57) in Japan. Anti-HAdV serum to HAdV-1, 2, 5, and 6 was quantitatively evaluated for cross-reactivity to the HAdV-57 isolates. Anti-HAdV-6 serum neutralized HAdV-57 with a concentration that was 32 to 64-fold higher than what was necessary to neutralize homologous HAdV-6. HAdV-1, 2, and 5 strains were not neutralized by anti HAdV-6 serum. Furthermore, 28 HAdV-6 strains isolated from 6,476 clinical samples were re-examined for HAdVs detected in the Shimane Prefecture of Japan from 2005 to 2014. These 28 strains were re-examined by PCR-sequencing techniques using the penton, hexon, and fiber regions. 3 isolates were determined to be HAdV-57. These data show that HAdV-57 had already invaded Japan as early as 2005, and that HAdV-57 strains were misidentified as HAdV-6.</description><subject>Adenoviruses</subject><subject>Cross-reactivity</subject><subject>fiber</subject><subject>hexon</subject><subject>Homology</subject><subject>human adenovirus 57</subject><subject>Neutralization</subject><subject>neutralization test</subject><subject>penton</subject><issn>1344-6304</issn><issn>1884-2836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkEtLAzEYRYMovn-BIANudDE172Q2QvHVFsGNug2ZJKOpbaYmM4L_3tTWgm6SfB_nXsIB4ATBgZCSXH617y4MJpPxzQBDJAZU8C2wj6SkJZaEb-c3obTkBNI9cJDSFELMGIK7YA9XAlYVr_bB1Z2PqSvG1oXON97ozrehaJti1M91KIZ533762KeCieJ8NLQvJRMXhQ_FRC90OAI7jZ4ld7y-D8Hz3e3T9ah8eLwfXw8fSsOR7Mq6IZpSWFmLKiItZYaxijjCqEVMEIQtqimvdY2IzqPVXAhpTG2NaaCoNTkE56veRWw_epc6NffJuNlMB9f2SWFICJFUYJ7Rs3_otO1jyL9TGOMK8iyPZYqsKBPblKJr1CL6uY5fCkG11Kt-9KqlXrXUq7LenDpdd_f13NlN5tdnBsYrYJo6_eo2gI6dNzO3LhVI0eXxp3zDmDcdlQvkG6NsjrU</recordid><startdate>20180731</startdate><enddate>20180731</enddate><creator>Tatsumi, Chika</creator><creator>Iizuka, Setsuko</creator><creator>Mita, Tetsuo</creator><creator>Wada, Mieko</creator><creator>Hanaoka, Nozomu</creator><creator>Fujimoto, Tsuguto</creator><general>National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee</general><general>Japan Science and Technology Agency</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20180731</creationdate><title>First Identification of Human Adenovirus 57 (HAdV-57) in Japan</title><author>Tatsumi, Chika ; Iizuka, Setsuko ; Mita, Tetsuo ; Wada, Mieko ; Hanaoka, Nozomu ; Fujimoto, Tsuguto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c618t-bf3a4409dd1938d45c5593e354d157312d1b46bab13a731da6778ccbdccf07ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adenoviruses</topic><topic>Cross-reactivity</topic><topic>fiber</topic><topic>hexon</topic><topic>Homology</topic><topic>human adenovirus 57</topic><topic>Neutralization</topic><topic>neutralization test</topic><topic>penton</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tatsumi, Chika</creatorcontrib><creatorcontrib>Iizuka, Setsuko</creatorcontrib><creatorcontrib>Mita, Tetsuo</creatorcontrib><creatorcontrib>Wada, Mieko</creatorcontrib><creatorcontrib>Hanaoka, Nozomu</creatorcontrib><creatorcontrib>Fujimoto, Tsuguto</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese Journal of Infectious Diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tatsumi, Chika</au><au>Iizuka, Setsuko</au><au>Mita, Tetsuo</au><au>Wada, Mieko</au><au>Hanaoka, Nozomu</au><au>Fujimoto, Tsuguto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First Identification of Human Adenovirus 57 (HAdV-57) in Japan</atitle><jtitle>Japanese Journal of Infectious Diseases</jtitle><addtitle>Jpn J Infect Dis</addtitle><date>2018-07-31</date><risdate>2018</risdate><volume>71</volume><issue>4</issue><spage>259</spage><epage>263</epage><pages>259-263</pages><issn>1344-6304</issn><eissn>1884-2836</eissn><abstract>Neutralization tests have been routinely used for the identification of human adenovirus C species (HAdV-C) in Japan until 2007. The aim of this study was to clarify the serological cross-reactivity of antiserum that has been used exclusively in Japan and to describe the first identification of HAdV type 57 (HAdV-57) in Japan. Anti-HAdV serum to HAdV-1, 2, 5, and 6 was quantitatively evaluated for cross-reactivity to the HAdV-57 isolates. Anti-HAdV-6 serum neutralized HAdV-57 with a concentration that was 32 to 64-fold higher than what was necessary to neutralize homologous HAdV-6. HAdV-1, 2, and 5 strains were not neutralized by anti HAdV-6 serum. Furthermore, 28 HAdV-6 strains isolated from 6,476 clinical samples were re-examined for HAdVs detected in the Shimane Prefecture of Japan from 2005 to 2014. These 28 strains were re-examined by PCR-sequencing techniques using the penton, hexon, and fiber regions. 3 isolates were determined to be HAdV-57. These data show that HAdV-57 had already invaded Japan as early as 2005, and that HAdV-57 strains were misidentified as HAdV-6.</abstract><cop>Japan</cop><pub>National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee</pub><pmid>29709969</pmid><doi>10.7883/yoken.JJID.2017.476</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1344-6304 |
| ispartof | Japanese Journal of Infectious Diseases, 2018/07/31, Vol.71(4), pp.259-263 |
| issn | 1344-6304 1884-2836 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2033384726 |
| source | J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; EZB-FREE-00999 freely available EZB journals |
| subjects | Adenoviruses Cross-reactivity fiber hexon Homology human adenovirus 57 Neutralization neutralization test penton |
| title | First Identification of Human Adenovirus 57 (HAdV-57) in Japan |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T01%3A19%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20Identification%20of%20Human%20Adenovirus%2057%20(HAdV-57)%20in%20Japan&rft.jtitle=Japanese%20Journal%20of%20Infectious%20Diseases&rft.au=Tatsumi,%20Chika&rft.date=2018-07-31&rft.volume=71&rft.issue=4&rft.spage=259&rft.epage=263&rft.pages=259-263&rft.issn=1344-6304&rft.eissn=1884-2836&rft_id=info:doi/10.7883/yoken.JJID.2017.476&rft_dat=%3Cproquest_cross%3E2229067885%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2229067885&rft_id=info:pmid/29709969&rfr_iscdi=true |